Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time.The company was founded in 2018 and is headquartered in Somerville, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 18, 2021 | Series B | $370M | 8 | — | — | Detail |
Sep 10, 2020 | Series Unknown | $50M | 1 | Flagship Pioneering | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Aug 31, 2021
Syndicate
|
Series A | $20M | Cryptocurrency | — |
Feb 5, 2020
Transparent Financial Systems
|
Series A | $14M | Banking | — |
Oct 5, 2019
Haystack
|
Pre-seed | $2M | Human Resources | — |
Jan 24, 2019
Liquid Death
|
Seed | $1.60M | Food and Beverage | — |
Oct 23, 2018
Envoy
|
Series B | $43M | Facility Management | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Abu Dhabi Investment Authority | — | Series B |
Alaska Permanent Fund | — | Series B |
Altitude Life Science Ventures | — | Series B |
ARCH Venture Partners | — | Series B |
Fidelity Management and Research Company | — | Series B |
Flagship Pioneering | — | Series B |
Morningside Venture Investments | — | Series B |
T. Rowe Price | — | Series B |